Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Johnson & Johnson's Blockbuster Drug Tremfya Clears Plaque Psoriasis With Lesions Covering Body's Smaller Areas

November 01, 2024
Johnson & Johnson has achieved a significant milestone with its blockbuster drug Tremfya, which has successfully cleared plaque psoriasis with lesions covering smaller areas of the body. The drug, which is part of the company's dermatology portfolio, has shown remarkable efficacy in clinical trials, offering new hope for patients suffering from this chronic skin condition. With this breakthrough, Johnson & Johnson reinforces its position as a leader in the pharmaceutical industry, dedicated to improving the lives of patients through groundbreaking medical advancements.

Find out how the JOHNSON & JOHNSON rate is expected to change

Get Forecast for JNJ

Investor opinions & comments:

I've been following the development of Tremfya and it's exciting to see that it has achieved such impressive results in clinical trials. I hope it becomes available soon for patients in need
— from CapitalChris at 11-04-2024 20:18
I'm skeptical about the effectiveness of Tremfya. We've seen many drugs claim to be breakthrough treatments for skin conditions before, but they often fall short of expectations
— from DividendDylan at 11-04-2024 19:34
It's concerning that the article mentions Tremfya only clearing plaque psoriasis with smaller lesions. What about patients with larger areas affected? Will they still benefit from this drug?
— from SavingsSandy at 11-04-2024 19:34
This is great news! Tremfya has the potential to greatly improve the lives of those suffering from plaque psoriasis. Can't wait to see the positive impact it will have
— from CashCharlie at 11-04-2024 19:03
As someone with plaque psoriasis, I am definitely interested in hearing more about Tremfya. I'm hopeful that it can provide relief for my condition
— from CapitalChris at 11-04-2024 18:27
While the results of the clinical trials are promising, I wonder about the potential side effects and long-term safety of Tremfya. More research and data are needed to truly assess its efficacy
— from RiskyRandy at 11-04-2024 18:20
I'm skeptical about this breakthrough. There have been numerous drugs in the past that have shown promise but ultimately failed to deliver long-term results. I hope Tremfya proves me wrong, but I'll remain cautiously optimistic
— from DividendDiane at 11-04-2024 18:09
I'm not convinced that Tremfya is the breakthrough it claims to be. We've seen similar claims in the past, only to find out that the results were not as promising as initially reported. I would like to see more independent studies
— from CashCasey at 11-04-2024 18:09
This is fantastic news! Tremfya clearing plaque psoriasis in smaller areas gives hope to all those who suffer from this condition. I can't wait to see how this drug can help improve the lives of patients
— from VictoriaGreen at 11-04-2024 18:09
Johnson & Johnson is truly an industry leader in pharmaceutical advancements. Their commitment to improving patient lives is evident, and Tremfya's efficacy in clearing plaque psoriasis is a testament to their dedication
— from MoneyMonique at 11-04-2024 18:08
This is incredible news for individuals suffering from plaque psoriasis! Tremfya's success in clearing smaller areas of the body is truly remarkable. It's heartening to see Johnson & Johnson's dedication to improving the lives of patients with dermatological conditions
— from MikeWilliams at 11-04-2024 18:07
While it's great that Tremfya has shown efficacy in clinical trials, I wonder about the potential side effects and long-term effects of this drug. More research and monitoring might be necessary before fully endorsing it
— from JacobYoung at 11-04-2024 18:07
Congratulations to Johnson & Johnson for achieving this significant milestone! Tremfya could be a game-changer for people living with plaque psoriasis
— from JoshuaAdams at 11-04-2024 18:00
This news shows the dedication of Johnson & Johnson to improving the lives of patients. Tremfya's success in clinical trials is a testament to the company's commitment to innovation and breakthrough therapies
— from WealthyWendy at 11-04-2024 17:48
If you want to leave a comment, then you need Login or Register





Other news for JNJ

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....



Related news

VRTXJanuary 22, 2025Vertex Pharmaceuticals Incorporated VRTX Leading the Trend: What You Should Know  ~2 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has been making waves in the stock market recently, attracting the attention of investors....

REGNJanuary 2, 2025Regeneron Pharmaceuticals: A Promising Future Ahead  ~2 min.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been making significant strides in the pharmaceutical industry, with investors enjoying a decent 89% return over the past five years....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

REGNJanuary 1, 2025Regeneron Pharmaceuticals, Inc.: Groundbreaking Discoveries in Drug Development  ~2 min.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has made remarkable progress in the field of drug development, delighting its investors with a decent 89% return over the past five years....

LLYJanuary 2, 2025Eli Lilly and Company's Groundbreaking Research Sets the Stage for Future Pharma Success  ~2 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its groundbreaking research and innovative solutions. The company's stock price might be down 0....